IDRA-21
People mainly take IDRA-21 for focus. Based on 13 first-hand reports. Ranked #1420 of 1,974 overall.
12
User score
Mixed0% positive15% mixed8% negative77% unclear
Of reports that state an outcome, 0% are positive.
Clinical research
Research pending
What IDRA-21 does, according to users
Of the people who reported each effect, the share who said it got better.
betterno changeworse
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
Research data for IDRA-21 is being compiled.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
7mg3-4 days
5 mgsingle dose
Reported side effects
How often each side effect came up across all reports.
anxiety ×1itching ×1anxiety when ×1dissociation ×1tachycardia ×1panic ×1
What users say
Verbatim quotes, shortened only — each links to the original discussion.
“If there is enough demand, we are going to get custom synths of things like GLYX-13 and IDRA-21.”
“If you smoke weed, I'd suggest picking up IDRA-21 next (they potentiate each other a LOT)”
“This is one of the few places you can talk about cerebrolysin peptides, semax and IDRA-21 and people will know and be able to relate to what you are speaking of.”
Other options for focus
Retatrutide
Peptide · 298 reports
100% report better focus
Mostly positiveBResearch: Moderate
Caffeine + L-Theanine
Supplement · 46 reports
91% report better focus
Mostly positive
Creatine Monohydrate
Supplement · 139 reports
94% report better focus
Mostly positiveAResearch: Strong
Semaglutide
Medication · 137 reports
67% report better focus
Mostly positiveAResearch: Strong
Intermittent Fasting
Lifestyle · 171 reports
94% report better focus
Mostly positive
Magnesium Glycinate
Supplement · 910 reports
70% report better focus
Mostly positiveCResearch: Limited
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate